Pansy Uberoi, MD
Urogynecology and Reconstructive Pelvic Surgery · Jbsa Lackland, TXNPI 1144665886
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,285 of the $8,414 with a category attached, or 86.6%. 10 manufacturers reported payments, led by Medtronic at 49.2% of the total. Reporting peaked in 2024 at $2,466 and has fallen 93.6% since, to $157 in 2025.
Across 101 payments — averaging $83.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Coloplast$2K
- Boston Scientific$950
- Axonics, Inc.$637
- Cook Medical LLC$105
- Convatec Inc.$104
- plus $285 from 4 others
Across 1 payment — averaging $355.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$355
What the payments were for
- Travel & lodging$1,12913%
- Food & beverage$7,28587%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 59 | $4,143 |
| Coloplast | 20 | $2,190 |
| Boston Scientific | 8 | $950 |
| Axonics, Inc. | 7 | $637 |
| Cook Medical LLC | 1 | $105 |
| Convatec Inc. | 1 | $104 |
| Neotract Inc. | 1 | $92 |
| Bluewind Medical | 1 | $86 |
| AbbVie(2 entities) | 2 | $84 |
| Tolmar, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$2,522
- ALTIS$1,204
- Axonics$286
- TITAN$258
- INTERSTIM ICON$160
- RESTORELLE$142
- Bulkamid$142
- AMS$116
- Cook Medical Holmium Laser Fiber$105
- GENTLECATH$104
- Axonics r-SNM System$103
How this compares
$8,414 in reported general payments places this provider in the 65th percentile of 74 urogynecology and reconstructive pelvic surgery providers in Texas.
See all urogynecology and reconstructive pelvic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 18 | $1,434 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Jbsa Lackland
- Stephen KrausSan Antonio$372K
- Keith XavierArlington$282K
- Tomas AntoniniAustin$183K
- Amanda WhiteAustin$108K
- Gazala SiddiquiHouston$81K
- Fiona LindoHouston$66K
- Peter LotzeHouston$48K
- Tracy Cannon-SmithArlington$29K
- Teresa IrwinSan Marcos$20K
- Oluwarotimi NetteyHouston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.